The Biology of Myelin and Identifying Look-Alikes
At a Glance
SPAX8 is an inherited disorder caused by changes in both copies of NKX6-2, a gene needed to build myelin and develop movement-control pathways. MRI findings, clinical examination, and genetic testing help distinguish it from similar leukodystrophies.
Understanding how NKX6-2-related leukodystrophy (also known as SPAX8) works at a biological level can help clarify why it affects movement and development. At its core, this condition is a problem with the brain’s “wiring” and the insulation that keeps that wiring efficient.
The Biological Blueprint
Every cell in your child’s body contains the NKX6-2 gene. This gene acts as a transcription factor, which you can think of as a “master switch” or a biological foreman that tells other genes when to turn on or off [1][2].
The NKX6-2 gene has two critical jobs in development:
- Building the Insulation: It is essential for the maturation of oligodendrocytes [2]. These are specialized cells in the brain that create myelin, the fatty, protective coating around nerve fibers. Without the NKX6-2 switch, these cells don’t fully mature, and the brain cannot produce enough myelin [1].
- Mapping the Motor Circuits: Research shows that this gene also helps develop the “circuits” in the spinal cord that control movement [3]. It helps ensure that certain motor neurons (the nerves that tell muscles to move) survive and reach their correct positions [3].
What is Hypomyelination?
In a healthy brain, myelin acts like the plastic coating on an electrical wire—it ensures that signals travel quickly and clearly from the brain to the muscles.
Hypomyelination means the brain has persistent or insufficient myelin for a person’s age [4]. Unlike “delayed myelination,” where the brain is just slow to build its coating, hypomyelination is a fundamental deficit. Doctors identify this on an MRI scan by looking at the color and “signal” of the white matter over time. When the imaging diagnosis is uncertain, some contexts use a six-month comparison (two scans taken at least six months apart showing the same lack of myelin) to classify it as hypomyelination, though this is an expert-guided option rather than a standalone universal rule [4][5].
It is also important to reconcile this with the later-onset NKX6-2 phenotype, which may have little apparent hypomyelination and more prominent cerebellar atrophy (shrinking of the balance center).
Distinguishing SPAX8 from “Look-Alikes”
Because many genetic conditions cause movement issues and myelin problems, SPAX8 can easily be mistaken for other disorders. Doctors use a combination of MRI patterns, physical exams, and genetic testing to tell them apart. (Note: This table provides examples for specialists rather than rules for self-diagnosis, as overlapping MRI findings mean clinical and genetic expertise is required.)
| Condition | Gene | Key Distinguishing Clues |
|---|---|---|
| SPAX8 | NKX6-2 | Early eye shaking (nystagmus) and a mix of floppiness and stiffness [6][1]. |
| 4H Leukodystrophy | POLR3A, POLR3B, POLR1C | Often includes hypodontia (missing teeth) and hypogonadotropic hypogonadism (hormonal issues that delay puberty) [7][8]. |
| H-ABC | TUBB4A | Characterized by a “shrinking” of the basal ganglia (a deep brain structure) seen on MRI [2]. |
| SPG58 | KIF1C | Usually presents as hereditary spastic paraplegia, focusing more on leg stiffness with specific MRI white matter changes [6]. |
| ARSACS | SACS | Often shows “pontine stripes” (specific lines on the brainstem) on MRI and retinal nerve-fiber-layer abnormalities in the eye [9][10]. |
How Doctors Confirm the Diagnosis
To ensure your child has the correct diagnosis, clinicians look for the “signature” of SPAX8:
- Persistent Hypomyelination: A lack of myelin that doesn’t improve on repeat MRIs [4].
- Cerebellar Atrophy: A shrinking of the cerebellum (the balance center), which is especially common in the milder, childhood-onset form [2].
- Genetic Testing: The most definitive way to differentiate these conditions is through biallelic variants (two mutations) in the NKX6-2 gene [1][6]. If the genetic test shows mutations in a different gene, like SACS or POLR3A, the diagnosis would change, as would the management plan.
Knowing the biological cause doesn’t change the daily care your child needs, but it does help your medical team narrow down which treatments and therapies are most likely to be helpful.
Common questions in this guide
What does the NKX6-2 gene do in SPAX8?
What does hypomyelination look like on an MRI?
How is SPAX8 distinguished from other leukodystrophies?
Can NKX6-2-related disease occur without obvious hypomyelination?
What does a biallelic NKX6-2 result mean?
Get notified when new evidence is published on NKX6-2-related autosomal recessive hypomyelinating leukodystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (10)
- 1
Biallelic mutations in the homeodomain of NKX6-2 underlie a severe hypomyelinating leukodystrophy.
Dorboz I, Aiello C, Simons C, et al.
Brain : a journal of neurology 2017; (140(10)):2550-2556 doi:10.1093/brain/awx207.
PMID: 28969374 - 2
Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination.
Chelban V, Patel N, Vandrovcova J, et al.
American journal of human genetics 2017; (100(6)):969-977 doi:10.1016/j.ajhg.2017.05.009.
PMID: 28575651 - 3
Onecut-dependent Nkx6.2 transcription factor expression is required for proper formation and activity of spinal locomotor circuits.
Toch M, Harris A, Schakman O, et al.
Scientific reports 2020; (10(1)):996 doi:10.1038/s41598-020-57945-4.
PMID: 31969659 - 4
Rare forms of hypomyelination and delayed myelination.
Mura E, Parazzini C, Tonduti D
Handbook of clinical neurology 2024; (204()):225-252 doi:10.1016/B978-0-323-99209-1.00002-8.
PMID: 39322381 - 5
Hypomyelinating disorders: An MRI approach.
Barkovich AJ, Deon S
Neurobiology of disease 2016; (87()):50-8.
PMID: 26477299 - 6
Genetic and phenotypic characterization of NKX6-2-related spastic ataxia and hypomyelination.
Chelban V, Alsagob M, Kloth K, et al.
European journal of neurology 2020; (27(2)):334-342 doi:10.1111/ene.14082.
PMID: 31509304 - 7
A novel homozygous synonymous variant further expands the phenotypic spectrum of POLR3A-related pathologies.
Lessel D, Rading K, Campbell SE, et al.
American journal of medical genetics. Part A 2022; (188(1)):216-223 doi:10.1002/ajmg.a.62525.
PMID: 34611991 - 8
Hypomorphic mutations in POLR3A are a frequent cause of sporadic and recessive spastic ataxia.
Minnerop M, Kurzwelly D, Wagner H, et al.
Brain : a journal of neurology 2017; (140(6)):1561-1578 doi:10.1093/brain/awx095.
PMID: 28459997 - 9
Widening the clinical, radiological and genetic spectrum of autosomal recessive ataxia of Charlevoix-Saguenay in Indian patients.
Divya KP, Cherian A, Dhing HK, et al.
Acta neurologica Belgica 2024; (124(2)):475-484 doi:10.1007/s13760-023-02400-0.
PMID: 37898963 - 10
Retinal Architecture in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): Insights into Disease Pathogenesis and Biomarkers.
Rezende Filho FM, Bremner F, Pedroso JL, et al.
Movement disorders : official journal of the Movement Disorder Society 2021; (36(9)):2027-2035 doi:10.1002/mds.28612.
PMID: 33893680
This page is for informational purposes only and does not constitute medical advice about your child’s MRI or genetic results. A pediatric neurologist and genetics team should interpret those findings and confirm the diagnosis.